Shopping Cart
- Remove All
- Your shopping cart is currently empty
FTase-IN-1 (compound 17a) is a highly effective farnesyl transferase (FTase) inhibitor with an IC50 value of 0.35 μM, demonstrating significant cytotoxicity and potent antitumor activity [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | FTase-IN-1 (compound 17a) is a highly effective farnesyl transferase (FTase) inhibitor with an IC50 value of 0.35 μM, demonstrating significant cytotoxicity and potent antitumor activity [1]. |
In vitro | FTase-IN-1 (compound 17a) at 10 μM over 48 hours inhibits farnesyl transferase (FTase) and significantly suppresses NCI-60 cell proliferation in vitro [1]. It halts various cancer cell lines' growth, achieving GI50 values of 1.8 to 6.5 nM [1]. Cell Viability Assays [1] show marked inhibition of cancer cell growth, including lung (NCI-H522), colon (COLO-205 and HT29), glioblastoma (SF-539), melanoma (MDA-MB-435), ovarian (OVCAR-3), and renal (A498) cancers. |
Molecular Weight | 384.45 |
Formula | C23H16N2O2S |
Cas No. | 2490538-41-3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.